Tagged with Pharm

Pharma Pascal Brossard, the Managing Director of Zambon France and President of Afipa (Association for the French self-medication medicines industry), reveals why he is confident that the self-medication market in France will witness substantial growth in the years ahead; and how as a family-run Italian company Zambon has a long-term vision,…

pharma   The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International companies must however adapt their strategies to suit the Thai market; as must domestic concerns. With an estimated value of USD 4.5 billion, Thailand is Southeast Asia’s second largest…

Pharma The president of Daiichi Sankyo France discusses the affiliate’s positioning and future strategy, the challenges for an international pharmaceutical company in France but also why the many strengths of France more than make up for these challenges, and finally, the unique aspects of Daiichi Sankyo’s corporate culture and core values.…

Pharma Paolo Casati, general manager for Santen’s new affiliate in Italy, discusses the company’s first full year in the country, its aims for contributing to the global group’s 2020 Vision by collaborating with Italy’s extensive network of key opinion leaders, as well as his desire to see Santen’s innovative drugs brought…

Pharma Paolo Cionini, General Manager of LEO Pharma Italy, discusses the initial challenges of setting up the Italian affiliate during the height of the global financial crisis in 2011, the company’s management culture, their emphasis on patient-centricity and holistic patient care, as well as the importance of maintaining a good relationship…

Pharma Europe’s longest-standing Minister of Health, Edith Schippers, provides insight into the local healthcare system and continued efforts to improve quality of life for Dutch citizens, as well as revealing the main policy priorities of the Ministry for the Dutch presidency of the European Union in the first semester of 2016.…

Pharma Sean Connor, General Manager Benelux and UK/ROI for ALK, details the company’s strategy both in terms of products and therapeutic areas and provides us with his assessment of Netherlands regulatory environment and market access. We are becoming, both at national and global levels, a company that supplies highly evidence-based medicines,…

Pharma Pharmed Healthcare is the only Egyptian company to hold a License from the innovator to produce generic sofosbuvir, but faces competition from at least ten different companies in the market. Given your experience in trying to combat the hepatitis C virus (HCV), which is an epidemic in Egypt, what are some…

Pharma The Managing Director of MSD Egypt highlights MSD’s unique incentives to further collaborate with the Egyptian medical community and explains how market peculiarities shape product launches in developing countries like Egypt. As newly appointed Managing Director for MSD Egypt, could you please outline your objectives and ambitions in the Egyptian…

Pharma Dr. Mohamed El Ganayni, Managing Director at UniPharma discusses the challenges in standing out among a crowd of Egyptian pharmaceutical manufacturers, elaborates on his ambitions to become a Top 30 local pharma player and gives an insight into his strategy to enter the European market by 2020. To begin, can…

Pharma Empty markets, where strong and growing demand exists but local supply does not, offer the most potential to prospective investors in Egypt, according to Delta Pharma Bio general manager Mohamed Aldeeb. Aldeeb goes on to explain that such markets include oncology, biosimilars, and baby formula. What makes Egypt ‘the land of…

Pharma Deputy Minister of Health for Pharmaceutical Affairs Tarek Salman discusses how pharmaceutical regulation in Egypt is taking a leap forward, with the introduction of new legislation with parallel registration process that will bring approval timelines under 21 months, and the imminent establishment of the Egyptian Drug Authority, which will merge…